Cite Filings / MDGL / 0000919574-16-014374
Feed Companies Filings Check
Sign in
SC 13D/A

Beneficial Ownership Report

MADRIGAL PHARMACEUTICALS, INC. · Filed 2016-08-01 · Acc 0000919574-16-014374

Documents 1

  • SC 13D/A Beneficial Ownership Report , d7220114_sc13d-a23.htm

Around this filing

  • 2019-10-17 SC 13D/A Beneficial Ownership Report
  • 2016-08-01 SC 13D/A Beneficial Ownership Report
  • 2016-07-29 3 Initial Statement of Ownership
  • 2016-07-29 3 Initial Statement of Ownership
  • 2016-07-26 4 Director acquired 5,953,921 shares (grant or award)
  • 2016-07-26 3 Initial Statement of Ownership
  • 2016-07-26 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-06 SCHEDULE 13D/A · Baker Bros. Advisors LP 9.99%
  2. 2025-12-12 SCHEDULE 13D/A · Rebecca Taub, M.D. 7.8%
  3. 2025-12-12 SCHEDULE 13D/A · Paul A Friedman, M.D. 7.8%
  4. 2024-11-14 SC 13G/A · Janus Henderson Group plc 11.4%
  5. 2024-11-14 SC 13G/A · PAULSON & CO. INC. 9.4%
  6. 2024-11-14 SC 13G · RTW Investments, LP 9.2%
  7. 2024-03-25 SC 13D/A · Baker Bros. Advisors LP 9.99%
  8. 2024-02-14 SC 13G/A · Armistice Capital, LLC 0.25%
  9. 2024-02-14 SC 13G/A · PAULSON & CO. INC. 5.6%
  10. 2024-02-14 SC 13G/A · Avoro Capital Advisors LLC 9.9%
Loading d7220114_sc13d-a23.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…